FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q2 2022

Top Holdings315 positions

Checking export access…
Activity:
SPYSPY
PUT

SPDR S&P 500 ETF TRUST

3.7M$1.4B7.6%———
Decreased
—

IQVIA HOLDINGS INC

3.2M$697.3M3.8%$145.73+46.93%
15 qtrssince 2018-Q4
Increased
60

THERMO FISHER SCIENTIFIC INC

1.2M$675M3.7%$393.62+36.27%
11 qtrssince 2019-Q4
Increased
59

TRANSUNION

7.5M$597M3.2%$92.47-15.36%
15 qtrssince 2018-Q4
Increased
69

BOSTON SCIENTIFIC CORP

15M$560.8M3.0%$38.68-3.64%
8 qtrssince 2020-Q3
Decreased
0

ARAMARK

16M$490.3M2.7%$24.80-14.81%
7 qtrssince 2020-Q4
Decreased
0

HOWMET AEROSPACE INC

13.8M$435.2M2.4%$28.78+7.89%
9 qtrssince 2020-Q2
Increased
54

ANTHEM INC

826,482$398.8M2.2%$291.80+58.23%
15 qtrssince 2018-Q4
Increased
58

CENTENE CORP

4.3M$367.3M2.0%$59.51+42.73%
10 qtrssince 2020-Q1
Increased
53

MASTERCARD INC - A

1.2M$363.2M2.0%$342.92-10.33%
6 qtrssince 2021-Q1
Increased
52
YMMYMM
ADR

FULL TRUCK ALLIANCE CO LTD

39.7M$359.5M1.9%$8.16-1.81%
5 qtrssince 2021-Q2
Increased
73

CLARIVATE PLC

24.6M$340.4M1.8%$15.06-6.15%
2 qtrssince 2022-Q1
Increased
79

WABTEC CORP

4M$327.5M1.8%$67.12+19.51%
15 qtrssince 2018-Q4
Decreased
0

MICROSOFT CORP

1.3M$326.9M1.8%$136.65+81.51%
15 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL C

143,407$313.7M1.7%$83.16+30.29%
15 qtrssince 2018-Q4
Decreased
0

DYNATRACE INC

7.8M$309.5M1.7%$41.510.00%
1 qtr
New
71
AZNAZN
ADR

ASTRAZENECA PLC

4.6M$305.9M1.7%$116.49+4.73%
4 qtrssince 2021-Q3
Increased
61

ACTIVISION BLIZZARD INC

3.9M$302.1M1.6%——
2 qtrssince 2022-Q1
Increased
56

COSTAR GROUP INC

5M$299.8M1.6%$60.210.00%
1 qtr
New
71

EQUIFAX INC

1.6M$295.6M1.6%$195.38-10.09%
15 qtrssince 2018-Q4
Increased
63
$18.4B
AUM
315
Positions
Q2 2022
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+19%Q1'21$19.2B+8%Q2'21$20.7B-10%Q3'21$18.6B-5%Q4'21$17.7B+2%Q1'22$18.1B-6%Q2'22$17B
Activity profile
$ moved · Q2'22
New22%Increased22%Decreased35%Exited20%
Composition
Equity vs derivatives
Equity92%Puts8%Calls0%
Holding period
Avg 1.1 years
<1Q7%1-4Q30%1-2Y48%2Y+15%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $18.4B across 315 positions as of Q2 2022. Top holdings: SPY puts (7.6%), IQV (3.8%), TMO (3.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q2 2022 Summary

Active quarter - 25 new positions, 30 exits, 49 increased. Top move: CLVT (INCREASED, conviction 79). Portfolio: $18.4B across 315 positions.

Top holdings by portfolio weight

Total AUM$17B
IQV3.78%
TMO3.66%
TRU3.24%
BSX3.04%
ARMK2.66%
HWM2.36%
ELV2.16%
CNC1.99%
MA1.97%
YMM1.95%
Other1.85%

Portfolio allocation by GICS sector

Sectors11
Healthcare33.05%
Unknown16.98%
Technology16.81%
Financial Services12.77%
Industrials10.01%
Communication Services5.15%
Real Estate3.05%
Basic Materials1.50%
Utilities0.40%
Energy0.28%
Other0.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L48
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBoston Scientific Corp
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used